BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34948304)

  • 1. Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.
    Dana P; Kariya R; Lert-Itthiporn W; Seubwai W; Saisomboon S; Wongkham C; Okada S; Wongkham S; Vaeteewoottacharn K
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
    Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
    Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses.
    Liu B; Yan S; Jia Y; Ma J; Wu S; Xu Y; Shang M; Mao A
    FEBS J; 2016 Oct; 283(20):3839-3850. PubMed ID: 27616304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
    Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S
    Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
    Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
    Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
    Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
    Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
    Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
    Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway.
    Hu MD; Jia LH; Wang ML
    Cell Biol Int; 2023 Aug; 47(8):1381-1391. PubMed ID: 37067236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
    Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
    Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor-associated macrophages.
    Ke K; Lin J; Huang N; Yan L; Liao R; Yang W
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1888. PubMed ID: 37688511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.
    Huang GL; Luo Q; Rui G; Zhang W; Zhang QY; Chen QX; Shen DY
    Mol Cell Biol; 2013 Sep; 33(17):3416-25. PubMed ID: 23798555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.
    Saengboonmee C; Phoomak C; Supabphol S; Covington KR; Hampton O; Wongkham C; Gibbs RA; Umezawa K; Seubwai W; Gingras MC; Wongkham S
    Life Sci; 2020 Dec; 262():118548. PubMed ID: 33038372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process.
    Dana P; Kariya R; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Matsuda K; Okada S; Wongkham S
    Oncol Res; 2017 Aug; 25(7):1047-1059. PubMed ID: 28244853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
    Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
    Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular IL-33 Attenuates Extracellular IL-33-induced Cholangiocarcinoma Cell Proliferation and Invasion
    Yangngam S; Thongchot S; Vaeteewoottacharn K; Thuwajit P; Hermoso MA; Okada S; Thuwajit C
    Anticancer Res; 2021 Oct; 41(10):4917-4928. PubMed ID: 34593439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Pugkhem A; Hahnvajanawong C; Chaiyagool J; Umezawa K; Okada S; Wongkham S
    PLoS One; 2014; 9(8):e106056. PubMed ID: 25170898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
    Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
    Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.